The downregulation of DNMT1 has been reported to suppress progression of breast cancer cells [15], and DNMT1 also can downregulate maternally expressed gene 3 (MEG3) expression through increasing methylation level of MEG3 in breast cancer [16]. This evidence concerns the gene MEG3 and breast carcinoma.